Phase 1 study with expansion cohorts of cabozantinib (C) + abiraterone (A) in metastatic castration resistant prostate cancer (mCRPC): Investigator-sponsored study. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sweeney, Christopher
  • Gray, Kathryn P
  • Harshman, Lauren Christine
  • Taplin, Mary-Ellen
  • Pace, Amanda Fredericks
  • Dumas, Kathryn
  • Supko, Jeffrey G
  • Zukotynski, Katherine
  • Bernard, Brandon David
  • Pomerantz, Mark
  • Elfiky, Aymen
  • Kantoff, Philip W

publication date

  • May 20, 2015